“利用自然截断的NS1基因研制犬流感H3N2候选活疫苗”的勘误表

IF 3 2区农林科学 Q2 INFECTIOUS DISEASES

Transboundary and Emerging Diseases Pub Date : 2025-09-02 DOI:10.1155/tbed/9796375

{"title":"“利用自然截断的NS1基因研制犬流感H3N2候选活疫苗”的勘误表","authors":"","doi":"10.1155/tbed/9796375","DOIUrl":null,"url":null,"abstract":"J. Hwang, S-W. Yoon, E. Ga, et al., “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene,” Transboundary and Emerging Diseases 2024, no. 1 (2024): 1–16, https://doi.org/10.1155/2024/4335836.In the article titled “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene,” some funding information was missed from the Acknowledgments section.The corrected section appears below:AcknowledgmentsThis study was financially supported by the Chonnam National University (Grant 2020-2073) and the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (Grants NRF-2020R1C1C1008347 and NRF-2021M3E5E3083401).We apologize for this error.","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2025 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/9796375","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene”\",\"authors\":\"\",\"doi\":\"10.1155/tbed/9796375\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"J. Hwang, S-W. Yoon, E. Ga, et al., “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene,” Transboundary and Emerging Diseases 2024, no. 1 (2024): 1–16, https://doi.org/10.1155/2024/4335836.In the article titled “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene,” some funding information was missed from the Acknowledgments section.The corrected section appears below:AcknowledgmentsThis study was financially supported by the Chonnam National University (Grant 2020-2073) and the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (Grants NRF-2020R1C1C1008347 and NRF-2021M3E5E3083401).We apologize for this error.\",\"PeriodicalId\":234,\"journal\":{\"name\":\"Transboundary and Emerging Diseases\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/tbed/9796375\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transboundary and Emerging Diseases\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/tbed/9796375\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/9796375","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

黄志强，吴绍文。Yoon， E. Ga，等，“利用自然截断的NS1基因开发犬流感H3N2活疫苗候选物”，《跨界与新发疾病》，2024年第1期。1 (2024): 1 - 16, https://doi.org/10.1155/2024/4335836.In题为“利用自然截断的NS1基因开发犬流感H3N2活疫苗候选物”的文章，在致谢部分遗漏了一些资助信息。本研究由全南国立大学（Grant 2020-2073）和韩国国家研究基金会（NRF）资助，由韩国政府（MEST）资助（Grant NRF- 2020r1c1c1008347和NRF- 2021m3e5e3083401）。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene”

J. Hwang, S-W. Yoon, E. Ga, et al., “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene,” Transboundary and Emerging Diseases 2024, no. 1 (2024): 1–16, https://doi.org/10.1155/2024/4335836.

In the article titled “Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene,” some funding information was missed from the Acknowledgments section.

The corrected section appears below:

Acknowledgments

This study was financially supported by the Chonnam National University (Grant 2020-2073) and the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (Grants NRF-2020R1C1C1008347 and NRF-2021M3E5E3083401).

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Transboundary and Emerging Diseases 农林科学-传染病学

CiteScore

8.90

自引率

9.30%

发文量

350

审稿时长

1 months

期刊介绍： Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions): Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread. Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope. Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies. Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies). Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.